Curis
CRIS
39 hedge funds and large institutions have $19.6M invested in Curis in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 4 closing their positions.
146% more call options, than puts
Call options by funds: $123K | Put options by funds: $50K
34% more capital invested
Capital invested by funds: $14.6M → $19.6M (+$4.99M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
3% more funds holding
Funds holding: 38 → 39 (+1)
0.01% more ownership
Funds ownership: 0.06% → 0.07% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$2.63M |
| 2 |
Renaissance Technologies
New York
|
+$385K |
| 3 |
JP Morgan Chase
New York
|
+$95.7K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$68.6K |
| 5 |
BTS
BB&T Securities
Richmond,
Virginia
|
+$53.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$1.06M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$99.9K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22.9K |
| 4 |
AL
Arnhold LLC
New York
|
-$19.5K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$16.9K |
CRIS Hedge Fund Activity: Q3 2019 in Review
39 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Curis (CRIS) for Q3 2019, worth a combined $19.6M — up 34% from $14.6M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CRIS positions and 4 closed out — a net gain of 1 holder — while 9 added to existing stakes and 9 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $2.63M. The largest seller was Fosun International, exiting entirely with an estimated $1.06M sold.
- 39 institutional investors held Curis (CRIS) as of Q3 2019, up from 38 in Q2 2019.
- Funds reported $19.6M of Curis stock for Q3 2019, up 34% quarter-over-quarter.
- 5 funds opened new Curis positions in Q3 2019 and 4 closed out, a net change of +1 holder.
- The largest Curis buyer in Q3 2019 was OrbiMed, an estimated $2.63M added.
- The largest Curis seller in Q3 2019 was Fosun International, an estimated $1.06M sold.
Based on aggregated 13F filings for Q3 2019.